Exhibit 107

Calculation of Filing Fee Tables

Form S-1

Vitro Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security	Security Class	Fee Calculation	Proposed Maximum Aggregate		Fee		Amount of Registration
	Type	Title	Rule	Offering(1)		Rate		Fee
Fees to Be Paid	Equity	Common Stock, par value $0.001 per share	457(o)	$	6,000,000		0.00014760	$	885.60
Fees to Be Paid	Equity	Overallotment Option Shares of Common Stock(2)	457(o)	$	900,000		0.00014760	$	132.84
Fees to Be Paid	Equity	Representative Warrants(3)	457(g)		—		—		—	(3)
Fees to Be Paid	Equity	Common Stock underlying Representative Warrants(4)	457(o)	$	362,250		0.00014760	$	53.47
		Total Offering Amounts		$	7,262,250		0.00014760	$	1,071.91
		Total Fees Previously Paid							3,531.99
		Total Fee Offsets							-
		Net Fee Due						$	-

(1)	Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457 under the Securities Act. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional shares of common stock as may be issued or issuable because of stock splits, stock dividends and similar transactions.
(2)	Represents 15% of additional shares of common stock related to the exercise in full of the over-allotment option by the underwriters.
(3)	No additional registration fee is payable pursuant to Rule 457(g) under the Securities Act.
(4)	Represents shares of common stock underlying the warrants issuable to the representative of the underwriters to purchase up to an aggregate of 5.0% of the common stock sold in the offering at an exercise price equal to 105% of the initial public offering price per security.